RockGen is a start-up biotechnology company with innovative goals to develop efficacious treatments for patients suffering from neurodegenerative diseases. We utilize cutting-edge research and investigating the central nervous system to develop novel medicine for Amyotrophic Lateral Sclerosis, Alzhe...
Use this information to figure out if this company is an ideal customer for you.
43 Talais Drive
Little Rock, 72223
RockGen's CEO is Mahmoud Kiaei
RockGen's HQ is located at 43 Talais Drive, Little Rock
RockGen's official website is rockgenbio.com
RockGen's revenue is $1M - $5M
RockGen has 11 - 50 employees
RockGen is in the industry of: Pharmaceuticals